Mac-2 binding protein glycosylation isomer as a novel predictive biomarker for patient survival after hepatitis C virus eradication by DAAs.

Mina NakagawaNobutoshi NawaEiko TakeichiTaro ShimizuJun TsuchiyaAyako SatoMasato MiyoshiFukiko Kawai-KitahataMiyako MurakawaSayuri NittaYasuhiro ItsuiSeishin AzumaSei KakinumaTakeo FujiwaraMamoru WatanabeYujiro TanakaYasuhiro Asahinanull null

Published in: Journal of gastroenterology (2020)

M2BPGi at SVR is a potential predictor for patients' survival and a candidate biomarker for detecting individuals who are at greater risk of death due to cancer-related and unrelated to HCV, as well as cardiovascular diseases, after viral eradication.

Keyphrases

hepatitis c virus
end stage renal disease
binding protein
cardiovascular disease
human immunodeficiency virus
newly diagnosed
chronic kidney disease
ejection fraction
prognostic factors
peritoneal dialysis
sars cov
type diabetes
patient reported outcomes
human health